CSB Alum in the News A grant from the National Human Genome Research Institute to Jackson Laboratory (JAX) Assistant Professor Albert Cheng, Ph.D., totaling $3,240,117 over five years, will fund the creation of a molecular “toolkit” to explore the effects of epigenetic modifications — chemical changes to DNA and histone proteins that affect how genes are…
Drug that targets a key cancer protein could combat leukemia and other types of cancer. MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive. The new peptide targets a protein called Mcl-1, which helps…
No Events Found!